Jonathan David Roth
8Patents
3h-index
16Co-inventors
50Inventor score
Filing activity: May 20, 2004 → Jan 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7723471B2 | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | Human Necessities | 18 | Active |
| US7399744B2 | Methods for affecting body composition | Human Necessities | 18 | Expired |
| US8426361B2 | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | Human Necessities | 14 | Active |
| US8394765B2 | Methods of treating obesity with two different anti-obesity agents | Human Necessities | 3 | Active |
| US9879063B2 | Engineered polypeptides having enhanced duration of action and reduced immunogenicity | Chemistry; Metallurgy | 1 | Active |
| US8906849B2 | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | Human Necessities | 0 | Active |
| US8748375B2 | Methods for affecting body composition using amylin agonists | Human Necessities | 0 | Active |
| US11535659B2 | Engineered polypeptides having enhanced duration of action | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.